Biogen Investigating Death Related to Brain Swelling in Aducanumab Patient
Biogen is investigating the death of a 75-year-old patient from cerebral edema that was possibly related to the antiamyloid antibody Aduhelm.
Source: Drug Industry Daily
Biogen is investigating the death of a 75-year-old patient from cerebral edema that was possibly related to the antiamyloid antibody Aduhelm.
Source: Drug Industry Daily